Acute Lung Injury Market Outlook (2026–2030): Trends and Growth Drivers

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Acute Lung Injury Market Between 2026 And 2030?

The acute lung injury market has experienced consistent expansion in recent years. This market is projected to expand from $2.59 billion in 2025 to $2.71 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 4.4%. Historically, this expansion has been driven by factors such as the significant occurrence of pneumonia and lung injuries linked to trauma, restricted availability of sophisticated ventilation systems, increasing understanding of critical care, the implementation of standard fluid management strategies, and a dependence on hospital-administered treatments.

The acute lung injury market size is projected to experience consistent expansion over the upcoming years, with an anticipated growth to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 4.2%. This growth can be attributed to several factors, including the development of novel pharmacotherapies for ALI, increasing integration of AI in patient monitoring, the global expansion of intensive care units, rising adoption of personalized treatment plans, and advancements in minimally invasive ventilation technologies. Concurrently, major trends in the forecast period include a rising incidence of acute lung injury cases globally, increased adoption of mechanical ventilation technologies, growing use of pharmacotherapy and fluid management, a focus on early diagnosis and monitoring tools, and the expansion of hospital-based critical care facilities.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report

Which Key Factors Are Driving The Acute Lung Injury Market Growth?

The increasing incidence of respiratory diseases is projected to drive the expansion of the acute lung injury market moving forward. Respiratory diseases are defined as conditions impacting the lungs and other components of the respiratory system, resulting in compromised lung function and breathing difficulties. The growing prevalence of these diseases is attributable to factors such as heightened air pollution, smoking, sedentary lifestyles, an aging population, and the influence of viral infections. Respiratory ailments, including pneumonia, lead to acute lung injury through the induction of severe inflammation and damage to the alveoli, culminating in impaired gas exchange and respiratory distress. As an illustration, in October 2024, the National Asthma Council, an Australia-based non-profit organization, stated that in 2023, Australia documented a total of 474 asthma-related deaths, encompassing 325 females and 149 males. This statistic is nearly identical to the 473 asthma-related fatalities noted in 2022, underscoring a steady trend in asthma mortality across both years. Consequently, the escalating occurrence of respiratory diseases is propelling the development of the acute lung injury market.

What Are The Different Segment Types In The Acute Lung Injury Market Segment Breakdown?

The acute lung injury market covered in this report is segmented –

1) By Injury Type: Direct Injury, Indirect Injury

2) By Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Direct Injury: Trauma-Induced Acute Lung Injury, Aspiration Pneumonitis, Pneumonia-Related Acute Lung Injury, Inhalation Injury

2) By Indirect Injury: Sepsis-Related Acute Lung Injury, Shock-Induced Acute Lung Injury, Acute Lung Injury Due To Blood Transfusion, Acute Lung Injury Associated With Pancreatitis

Which Trends Are Guiding The Direction Of The Acute Lung Injury Market?

Key companies within the acute lung injury treatment sector are prioritizing the creation of advanced therapies, including recombinant human plasma gelsolin (rhu-pGSN), aimed at restoring balance to dysfunctional inflammation, managing vital immune responses, and potentially enhancing patient results in cases of severe lung injury. Rhu-pGSN is derived from gelsolin, a protein that is highly conserved and essential for controlling immune dysregulation in acute respiratory distress syndrome (ARDS). For example, in June 2025, BioAegis Therapeutics, a US biotech firm, was granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for its leading product, rhu-pGSN, intended for ARDS treatment. This particular therapy presents several distinct advantages, such as rebalancing impaired inflammation without suppressing immune function, regulating crucial immune responses within the lungs, and potentially bettering outcomes for individuals with severe inflammatory lung injuries.

Who Are The Well-Known Companies In The Acute Lung Injury Market?

Major companies operating in the acute lung injury market are Medtronic plc, Baxter International Inc., GE Healthcare Technologies Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Koninklijke Philips N.V., Hamilton Medical AG, Vyaire Medical Inc., Vapotherm Inc., GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Faron Pharmaceuticals Oy, Windtree Therapeutics Inc., Apeiron Biologics AG, ReAlta Life Sciences Inc., Vasomune Therapeutics Inc., MediciNova Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc.

Get The Full Acute Lung Injury Market Report:

https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report

Which Geographic Region Dominates The Acute Lung Injury Market?

North America was the largest region in the acute lung injury market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Acute Lung Injury Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report

Browse Through More Reports Similar to the Global Acute Lung Injury Market 2026, By The Business Research Company

Acute Spinal Cord Injury Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

Interstitial Lung Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report

Acute Respiratory Distress Syndrome Ards Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795